Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bispecific Single-Domain Antibodies as Highly Standardized Synthetic Calibrators for Immunodiagnosis

  • Segovia-de los Santos, Paula
  • Echaides, Cesar
  • Lassabe, Gabriel
  • Gonzalez-Sapienza, Gualberto
  • Quintero-Campos, Pedro|||0000-0002-9398-5077
  • Morais, Sergi|||0000-0002-3722-2358
  • Maquieira, Angel|||0000-0003-4641-4957
[EN] Commonly, serological immunoassays and diagnostic kits include reference standard reagents (calibrators) that contain specific antibodies to be measured, which are used for the quantification of unknown antibodies present in the sample. However, in some cases, such as the diagnosis of allergies or autoimmune diseases, it is often difficult to have sufficient quantities of these reference standards, and there are limitations to their lot-to-lot reproducibility and standardization over time. To overcome this difficulty, this study introduces the use of surrogate recombinant calibrators formulated on the basis of two single-domain antibodies (nanobodies) combined through a short peptide linker to produce a recombinant bispecific construct. One of the nanobodies binds to the cognate analyte of the target antibody and the second is specific for the paratope of the secondary detecting antibody. The bispecific nanobody inherits the outstanding properties of stability and low-cost production by bacterial fermentation of the parent nanobodies, and once calibrated against the biological reference standard, it can be reproduced indefinitely from its sequence in a highly standardized manner. As a proof of concept, we present the generation and characterization of two bispecific calibrators with potential application for the diagnosis of allergy against the antibiotics aztreonam and amoxicillin in humans., This work was supported by CSIC 2007-348, ANII FMV 2019_156321, and ANII FMV 2018_148245. P.S. is a recipient of a scholarship from ANII-Uruguay. P.Q.-C. acknowledges financial support from Generalitat Valenciana through the research staff training program (GVA ACIF/2018/173) . This research was also funded by Agencia Estatal de Investigacion (PID2019-110713RB-I00, FEDER) , program UPV-La FE 2019 (P105 VALBIOAL) , and PROMETEO/2020/094.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

An ultra-sensitive homologous chemiluminescence immunoassay to tackle penicillin allergy

  • Quintero-Campos, Pedro|||0000-0002-9398-5077
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
  • Segovia-de los Santos, Paula
  • Ibáñez-Echevarría, Ethel
  • Hernández-Fernández de Rojas, Dolores
  • Casino, Patricia
  • Lassabe, Gabriel
  • Gonzalez-Sapienza, Gualberto
[EN] Penicillin is one of the most widely used antibiotics to treat bacterial infections in clinical practice. The antibiotic undergoes degradation under physiological conditions to produce reactive compounds that in vivo bind self- proteins. These conjugates might elicit an immune response and trigger allergic reactions challenging to di- agnose due to the complex immunogenicity. Penicillin allergy delabeling initiatives are now part of antibiotic stewardship programs and include the use of invasive and risky in vivo tests. Instead, the in vitro quantification of specific IgE is highly useful to confirm immediate allergy to penicillins. However, discrepant results associated with the low sensitivity and accuracy of penicillin allergy in vitro tests have limited their routine diagnostic use for delabeling purposes. We aimed to develop a homologous chemiluminescence-based immunochemical method for the reliable determination of specific IgE to penicillin G, using unprecedented synthetic human-like Analytica Chimica Acta 1214 (2022) 339940 2standards. The synthetic standard targets the major antigenic determinant of penicillin G and the paratope of Omalizumab, acting as human-like specific IgE. It is a potent calibrator, highly stable, easy, and inexpensive to produce, overcoming the limitations of the pooled human serum preparations. The developed method achieved a good agreement and strong positive relationship, reaching a detection limit below 0.1 IU mL, P.Q-C acknowledges financial support from Generalitat Valenciana through the research staff-training program (GVA ACIF/2018/173). P.C. awards grants Ramon y Cajal and PID2019-110630 GB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe¿. S.M awards grants PID2019-110713RB-I00 funded by MCIN/ AEI/10.13039/501100011033 and by ERDF A way of making Europe. PROMETEO/2020/094 funded by Generalitat Valenciana, and program UPV-La FE 2019 (P105 VALBIOAL), FMV-ANII 148245, FMV-ANIII 156321 funded by Agencia Nacional de Investigacion and CSIC 2007- 348 UdelaR, Uruguay, are also acknowledged.